page contents

Cramer Remix: How this drug stock put the bear case to rest

For CNBC’s Jim Cramer, it’s often worth examining stocks that don’t get dragged down by broader market declines. On Friday, one such stock was Eli Lilly, which surged 1.8 percent to $ 115.02 a share…
Business News

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.